Insight & Updates

Insights & Updates

Insights, Research & Industry Updates

Cyclotek validates to cGMP 18F FP-CIT (PET DAT Scan) for use in Parkinson Disease

Cyclotek lends a hand in PSMA-PET in Active Surveillance for Ca Prostate

PSMA PET scans for prostate cancer will be funded through the Medical Benefits Schedule (MBS)

Cyclotek supports Macquarie University’s Research Studies in Motor Neuron Disease (MND)

Cyclotek announces the CRIB Project at Bio21

Advanced manufacturing in Australia: Applied Molecular Therapies launches its first thernostic product in prostate cancer treatment

A conversation with Prof. Terry O’Brien and Dr. Lucy Vivash on the future of positron emission tomography (PET) in neurology

Women in Nuclear: a conversation with Eden Carnegie on Quality Assurance

New Joint Venture to manufacture GMP theranostic radiopharmaceuticals in Australia